lunes, 21 de septiembre de 2020

CDER New: 9/21/2020



What's New Related to Drugs
September 18, 2020

Recent New and Generic Drug Approvals

This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.

September 18, 2020

Drug Name and
Application Number
Active IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission Status
Cefobid
NDA #050551
Cefoperazone SodiumInjectable; InjectionSUPPL-46PfizerLabelingApproved
Armonair Digihaler
NDA #208798
Fluticasone PropionatePowder; InhalationSUPPL-7Teva PharmLabelingApproved
Armonair Respiclick
NDA #208798
Fluticasone PropionatePowder; InhalationSUPPL-7Teva PharmLabelingApproved

September 17, 2020

Drug Name and
Application Number
Active IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission Status
Desmopressin Acetate
ANDA #210223
Desmopressin AcetateInjectable; InjectionORIG-1Ubi Approved
Yonsa
NDA #210308
Abiraterone AcetateTablet; OralSUPPL-1Sun Pharma GlobalLabelingApproved
Potassium Chloride
ANDA #210395
Potassium ChlorideTablet, Extended Release; OralORIG-1Zydus Pharms Approved
Erythromycin Lactobionate
ANDA #211086
Erythromycin LactobionateInjectable; InjectionORIG-1Exela Pharma Approved
Potassium Chloride 0.15% In Sodium Chloride 0.45%
ANDA #212347
Potassium Chloride; Sodium ChlorideInjectable; InjectionORIG-1Fresenius Kabi Usa Approved
Potassium Chloride 0.3% and Sodium Chloride 0.9%
ANDA #212347
Potassium Chloride; Sodium ChlorideInjectable; InjectionORIG-1Fresenius Kabi Usa Approved

No hay comentarios: